Te group of Dr Atocha Romero has just published the terrific results of the NADIM phase II trial, showing that ctDNA levels were significantly associated with OS and outperformed radiologic assessments in the prediction of survival.
The manuscript is available at
https://ascopubs.org/doi/full/10.1200/JCO.21.02660#.YoK7H6Useqs.twitter